CEA (carcinoembryonic antigen) is a protein which is generally made in the fetus at its development stage. This protein vanishes or does not exist in adults. Its irregular quantities may cause cancer. CEA test is carried out to determine protein levels and test the reappearance of colon and other cancers.
Constant technical developments, consequent to the identification of particular antigens are one of the primary causes for the expansion of the CEA testing market. Rising population of old people and scientific advancements which help expose the hereditary source of the illness also help drive this market.
Meticulous research and development projects and growing precision of investigative practices propel the CEA testing market ahead.